EE554 Costs Comparison Between Dupilumab and Omalizumab in the Treatment of Severe Allergic Asthma in the Brazilian Private Healthcare Perspective

Dec 1, 2022, 00:00 AM
10.1016/j.jval.2022.09.795
https://www.valueinhealthjournal.com/article/S1098-3015(22)02999-0/fulltext
Section Title :
Section Order : 10335
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02999-0&doi=10.1016/j.jval.2022.09.795
HEOR Topics :
Tags :
Regions :